ImmuCell Corporation (ICCC)

ImmuCell Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	30.68	27.64	26.49	17.47	18.57	19.24
Revenue Growth	8.49%	4.35%	51.63%	-5.90%	-3.51%	25.42%
Gross Profit Gross Profit Growth	12.37	11.45	7.94	3.87	7.65	8.66
Operating Income Operating Income Growth	3.87	1.65	-1.64	-5.75	-2.3	0.26
Net Income Net Income Growth	0.79	-1.04	-2.16	-5.77	-2.49	-0.08
Earnings Per Share EPS Growth	0.07	-0.12	-0.26	-0.75	-0.32	-0.01
EPS Growth	-63.16%	-	-	-	-	-

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Mastitis Mastitis Growth	0.2	0.18	0.18	0.15	0.14
Scours Scours Growth	27.45	26.31	17.29	18.41	18.93
Total Total Growth	27.64	26.49	17.47	18.57	19.24

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	8.86	3.81	3.76	0.98	5.79	10.19
Total Debt Total Debt Growth	12.45	13.19	15.1	16.69	12.48	10.27
Net Cash (Debt) Net Cash Growth	-3.59	-9.39	-11.34	-15.71	-6.69	-0.09
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.40	-1.04	-1.39	-2.03	-0.86	-0.01

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	5.89	2.48	0.36	-4.67	-1.54	0.95
Capital Expenditures CapEx Growth	-1.68	-1.25	-0.47	-1.89	-3.98	-2.61
Free Cash Flow Free Cash Flow Growth	4.21	1.22	-0.11	-6.57	-5.52	-1.65
Free Cash Flow Growth	138.91%	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	40.32%	41.40%	29.97%	22.15%	41.19%	44.98%
Operating Margin	12.60%	5.97%	-6.19%	-32.90%	-12.38%	1.34%
Pretax Margin	2.78%	-3.72%	-8.10%	-33.02%	-13.39%	-0.36%
Profit Margin	2.57%	-3.76%	-8.14%	-33.05%	-13.43%	-0.41%
FCF Margin	13.74%	4.43%	-0.41%	-37.59%	-29.72%	-8.60%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
P/FCF Ratio	29.21	45.42	-	-	-	-
PS Ratio	3.29	2.01	1.75	2.26	2.55	3.22

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Aug 14, 2026

Data Sources Report a data error